Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

Start Learning

Touch Loading image
CONFERENCE HUB
Start Learning
RIO phase II study reveals promise for broadly neutralising antibodies in achieving HIV remission without daily antiretroviral therapy
The Golden Gate Bridge at Sunset, San Francisco , CA
JOURNALS
Start Learning
CROI 2025: The countdown is on!
touchIN CONVERSATION
Start Learning
Selecting ART: Working with people living with HIV to find the best regimen
JOURNALS
Start Learning
Vaccinating children in endemic regions could be the most efficient strategy for tackling mpox in the Democratic Republic of the Congo
JOURNALS
Start Learning
#ShowYourStripes for Rare Disease Day!
virus closeup, contagious pathogen. Monkey pox virus closeup, contagious pathogen, infectious zoonotic disease
JOURNALS
Start Learning
Mpox: Current Clinical Considerations on Antiviral Treatment
HIV
JOURNALS
Start Learning
The HIV vaccine race: Challenges and breakthroughs with Dr Amesika Nyaku
JOURNALS
Start Learning
ASRA Pain Medicine release groundbreaking new surgical infection prevention guidelines
JOURNALS
Start Learning
Rare pneumonic plague-related death sparks health advisory
JOURNALS
Start Learning
Avoiding Multidrug Resistance in a Hospital Setting

to view Favourites, Keep Notes and Track CME Credits

Favourites
A warm welcome to Dr Jon Salmanton-García to our touchINFECTIOUS DISEASES Editorial Board!
View
ESCMID Global 2025 Young Investigator awardee Dr Simon Feys on ICU Medicine and Infectious Disease: touchINFECTIOUS DISEASES Future Leader 2025
View
RIO phase II study reveals promise for broadly neutralising antibodies in achieving HIV remission without daily antiretroviral therapy
View
Selecting ART: Working with people living with HIV to find the best regimen
View
Towards personalized care for people living with HIV: Supporting open dialogue and informed treatment choices
View
ASRA Pain Medicine release groundbreaking new surgical infection prevention guidelines
View
Rare pneumonic plague-related death sparks health advisory
View
#ESCMIDGlobal2025: Dr Jon Salmanton-García on addressing respiratory virus risks in haematological malignancies
View
Medics For Rare Disease – New Year, New Strategy
View
CROI 2025: The countdown is on!
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup